Hyperspectral imaging, a technology used by the U.S. space agency, may offer a major step forward in food testing to prevent wastage. » Read More
By: Carmin Chappell
AbbVie shares fell almost 3 percent on Tuesday following a lawsuit by the California Department of Insurance alleging that the pharmaceutical company gave health-care providers kickbacks to prescribe its arthritis drug Humira. » Read More
By: Qingyao Kong, University of Chicago
Researchers at the University of Chicago have developed and tested a way to block cocaine craving and addiction, protecting addicts from high doses that would otherwise be deadly. » Read More
Paul Singer of Elliott Management could be mulling a bid at a lower price, according to the New York Post. » Read More
Trump suggested in the debate that Canadians come to the US when they need a big operation because their health-care system is so slow. Not true, says Vox's Julia Belluz.
Betadine-maker Mundipharma's new alliance with Manchester City all part of the pharma firm's EM strategy, the company told CNBC.
Former Silicon Valley darling Theranos will close its labs and Wellness Centers, CEO Elizabeth Holmes revealed in a public letter to "stakeholders."
The world's oldest people may have attained the oldest age biologically possible for the human species.
Acute flaccid myelitis (AFM) — a mysterious muscle weakness, similar to polio — appears to be on the rise this year, reports NBC.
Congress demanded more documents about how much Mylan actually makes on EpiPen anti-allergy devices, which have skyrocketed in price.
Japan's Yoshinori Ohsumi won the 2016 Nobel prize for medicine or physiology for his discovery of how cells break down and recycle their content.
Shares of Depomed had spiked as much as 13 percent before the trading halt.
Mylan CEO testified before a House panel that EpiPen prices went up because of investing upgrades, according to NBC.
The White House is at it again — trying to use sneaky plans to bail out Obamacare instead of tearing it up and starting over, says Jake Novak.
Obamacare regulations are soaring to all-time highs, Cleveland Clinic CEO Dr. Toby Cosgrove tells CNBC.
Older people are more at risk for the flu, but officials say everyone older than 6 months should get vaccinated.
Regulators said they have told Mylan that it should be paying higher rebates on sales of EpiPens through Medicaid.
Aetna will be giving 50,000 of its employees free Apple Watches and will deduction to customers buying them, reported NBC Connecticut.
A restatement by Mylan of EpiPen profit figures is just the latest problem for the drugmaker.
A potent opioid called carfentanil has led to hundreds of overdoses in Ohio, overwhelming police and first responders, NPR reports.
It's "certainly clear that there will be negative impact going forward," but one analyst said the stock has already seen the worst.
Quest Diagnostics on Wednesday announced the availability of a new test service that aids the diagnosis of infection with the Zika virus.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
GlaxoSmithKline said on Tuesday it had chosen Emma Walmsley, head of consumer healthcare, as its new chief executive, after considering internal and external candidates.